A feasibility study of TS-1 and oxaliplatin for Stage III gastric cancer in adjuvant setting
Not Applicable
- Conditions
- Gastric Cancer
- Registration Number
- JPRN-UMIN000023560
- Lead Sponsor
- Department of Surgical Oncology, Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. With synchronous or metachronous (within 5 year before entry) double cancer, except for situ carcinoma 2. Severe surgical complication 3. Severe complication; such as uncontrollable diabetes mellitus or hypertension 4.With Peripheral sensory neuropathy 5. Active infectious disease 6. Positive for HBs antigen or HCV antibody 7. Continuous administration of steroids 8. Severe diarrhea 9. With drug allergy for both of iodine and gadolinium 10. Continuous flucytosine, phenytoin, and warfarin potassium treatment 11. Women during pregnancy, possible pregnancy, or breast-feeding and men with making pregnant 12. Cases judged to be inappropriate by attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method